Cialis (tadalafil) promoted for benign prostatic hyperplasia (BPH)
September 2012
You'll see Cialis (tadalafil) promoted for benign prostatic hyperplasia (BPH)...not just erectile dysfunction.
It's the first phosphodiesterase-5 inhibitor to be approved in Canada for BPH symptoms.
Over half of men over age 50 have lower urinary tract symptoms...urinary frequency, hesitancy, etc...and they increase with age.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive